Hansa Biopharma advances to commercial stage following conditional EU approval of Idefirix; Positive high-level data from investigator-initiated phase 2 trial with imlifidase in anti-GBM
PR Newswire
LUND, Sweden, Oct. 22, 2020
PR Newswire
LUND, Sweden, Oct. 22, 2020
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey